RNAscope™ technology is being routinely used for tissue-based gene expression analysis in biopharma for target validation, pathobiology and biomarker development in every disease area. This technology, with its capacity to provide single-cell and single-RNA molecule sensitivity in the context of complex tissue microenvironments, is an ideal tool to complement technologies like IHC, qPCR or NGS.

Our recent advances in RNAscope™ technology, now enables detection of any mRNA, RNA mutations, and exon junctions. The presenters at this symposium will discuss how they have successfully applied RNA ISH to their research and will highlight the benefits of RNAscope™ technology.

REGISTER